外泌体在乳腺癌中的研究进展

Abstract
Figure/Table
References (37)
Related Citation (15)

Download: PDF (518 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Breast cancer cells leave the primary tissue and enter the circulatory system, along the circulatory system to reach the target organs, and eventually form distal metastasis and recurrence of breast cancer, which is the main cause of death of breast cancer patients. Exosomes are small lipid bilaterals released by pluripotent cells, which regulate complex cellular pathways and are involved in all stages of breast cancer from the onset to the spread of metastasis. Studies have shown that exosomes are closely related to breast cancer metastasis, which can promote tumor angiogenesis, help tumor escape the monitoring of the immune system and inhibit immune cells. In this review, we will discuss the role of exosomes in the occurrence and development of breast cancer from the structure of exosomes, and reveal whether exosomes can provide new prospects for the early diagnosis and molecular targeted therapy of breast cancer.

Key words： Exosomes Breast cancer Diagnosis Treatment

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	XU Jiahan YAO Yongzhong▲

Cite this article:

XU Jiahan YAO Yongzhong▲. Research progress of exosomes in breast cancer[J]. 中国医药导报, 2021, 18(18): 44-47.

URL:

https://www.yiyaodaobao.com.cn/EN/ OR https://www.yiyaodaobao.com.cn/EN/Y2021/V18/I18/44

[1] Bray F，Ferlay J，Soerjomataram I，et al. Global cancer statistics 2018：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin，2018，68（6）：394-424.
[2] Raposo G，Stoorvogel W. Extracellular vesicles：exosomes，microvesicles，and friends [J]. J Cell Biol，2013，200（4）：373-383.
[3] Valadi H，Ekstrom K，Bossios A，et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells [J]. Nat Cell Biol，2007，9（6）：654-659.
[4] Whiteside TL. Tumor-derived exosomes and their role in cancer progression [J]. Adv Clin Chem，2016，74：103-141.
[5] Adem B，Vieira PF，Melo SA. Decoding the biology of exosomes in metastasis [J]. Trends Cancer，2020，6（1）：20-30.
[6] Jabbari N，Akbariazar E，Feqhhi M，et al. Breast cancer-derived exosomes：tumor progression and therapeutic agents [J]. J Cell Physiol，2020，235（10）：6345-6356.
[7] Hurley JH. ESCRTs are everywhere [J]. EMBO J，2015，34（19）：2398-2407.
[8] Bebelman MP，Smit MJ，Pegtel DM，et al. Biogenesis and function of extracellular vesicles in cancer [J]. Pharmacol Ther，2018，188：1-11.
[9] Riches A，Campbell E，Borger E，et al. Regulation of exosome release from mammary epithelial and breast cancer cells-a new regulatory pathway [J]. Eur J Cancer，2014，50（5）：1025-1034.
[10] Giordano C，Barone L，Barone I，et al. Leptin modulates exosome biogenesis in breast cancer cells：an additional mechanism in cell-to-cell communication [J]. J Clin Med，2019，8（7）：1027.
[11] Filipazzi P，Bürdek M，Villa A，et al. Recent advances on the role of tumor exosomes in immunosuppression and disease progression [J]. Semin Cancer Biol，2012，22（4）：342-349.
[12] Gu J，Qian H，Shen L，et al. Gastric cancer exosomes trigger differentiation of umbilical cord derived mesenchymal stem cells to carcinoma-associated fibroblasts through TGF-β/Smad pathway [J]. PLoS One，2012，7（12）：e52465.
[13] Basu S，Bhattacharyya SN. Insulin-like growth factor-1 prevents miR-122 production in neighbouring cells to curtail its intercellular transfer to ensure proliferation of human hepatoma cells [J]. Nucleic Acids Res，2014，42（11）：7170-7185.
[14] Kruger S，Abd Elmageed ZY，Hawke DH，et al. Molecular characterization of exosome-like vesicles from breast cancer cells [J]. BMC Cancer，2014，14：e44.
[15] Gangoda L，Liem M，Ang CS，et al. Proteomic profiling of exosomes secreted by breast cancer cells with varying metastatic potential [J]. Proteomics，2017，17：23-24.
[16] Campos A，Salomon C，Bustos R，et al. Caveolin-1-containing extracellular vesicles transport adhesion proteins and promote malignancy in breast cancer cell lines [J]. Nanomedicine（Lond），2018，13（20）：2597-2609.
[17] Liu T，Zhang Q，Zhang J，et al. EVmiRNA：a database of miRNA profiling in extracellular vesicles [J]. Nucleic Acids Res，2019，47（D1）：D89-D93.
[18] Stevic I，Müller V，Weber K，et al. Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial [J]. BMC Med，2018， 16（1）：179.
[19] Kia V，Mortazavi Y，Paryan M，et al. Exosomal miRNAs from highly metastatic cells can induce metastasis in non-metastatic cells [J]. Life Sci，2019，220：162-168.
[20] Yang M，Chen J，Su F，et al. Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells [J]. Mol Cancer，2011，10：e117.
[21] Menck K，Klemm F，Gross JC，et al. Induction and transport of Wnt 5a during macrophage-induced malignant invasion is mediated by two types of extracellular vesicles [J]. Oncotarget，2013，4（11）：2057-2066.
[22] Maji S，Chaudhary P，Akopova I，et al. Exosomal annexin Ⅱ promotes angiogenesis and breast cancer metastasis [J]. Mol Cancer Res，2017，15（1）：93-105.
[23] Chaudhary P，Gibbs LD，Maji S，et al. Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis [J]. Breast Cancer Res，2020，22（1）：11.
[24] Fasanaro P，D’Alessandra Y，Di Stefano V，et al. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A [J]. J Biol Chem，2008，283（23）：15878-15883.
[25] Wen SW，Sceneay J，Lima LG，et al. The biodistribution and immune suppressive effects of breast cancer-derived exosomes [J]. Cancer Res，2016，76（23）：6816-6827.
[26] Liu C，Yu S，Zinn K，et al. Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function [J]. J Immunol，2006，176（1）：1375-1385.
[27] Xing F，Liu Y，Wu SY，et al. Loss of XIST in Breast Cancer Activates MSN-c-Met and Reprograms Microglia via Exosomal miRNA to Promote Brain Metastasis [J]. Cancer Res，2018，78（15）：4316-4330.
[28] Chow A，Zhou W，Liu L，et al. Macrophage immunomodulation by breast cancer-derived exosomes requires toll-like receptor 2-mediated activation of NF-κB [J]. Sci Rep，2014，4（18）：1-11.
[29] Hoshino A，Costa-Silva B，Shen TL，et al. Tumour exosome integrins determine organotropic metastasis [J]. Nature，2015，527（7578）：329-335.
[30] Zhou W，Fong MY，Min Y，et al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis [J]. Cancer Cell，2014，25（4）：501-515.
[31] Feng T，Zhang P，Zhang P，et al. High throughput sequencing identifies breast cancer-secreted exosomal LncRNAs initiating pulmonary pre-metastatic niche formation [J]. Gene，2019，710：258-264.
[32] Hannafon BN，Trigoso YD，Calloway CL，et al. Plasma exosome microRNAs are indicative of breast cancer [J]. Breast Cancer Res，2016，18（1）：90.
[33] Galindo-Hernandez O，Villegas-Comonfort S，Candanedo F，et al. Elevated concentration of microvesicles isolated from peripheral blood in breast cancer patients [J]. Arch Med Res，2015，44（3）：208-214.
[34] Khan S，Bennit HF，Turay D，et al. Early diagnostic value of survivin and its alternative splice variants in breast cancers [J]. BMC Cancer，2012，30（27）：35.
[35] Malhotra H，Sheokand N，Kumar S，et al. Exosomes：tunable nano vehicles for macromolecular delivery of transferrin and lactoferrin to specific intracellular compartment [J]. J Biomed Nanotechnol，2016，12（5）：1101-1114.
[36] Lamichhane TN，Jeyaram A，Patel DB，et al. Oncogene knockdown via active loading of small RNAs into extracellular vesicles by sonication [J]. Cell Mol Bioeng，2016， 9（3）：315-324.
[37] Pascucci L，Coccè V，Bonomi A，et al. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth：a new approach for drug delivery [J]. J Control Release，2014， 192：262-270.